🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Precocious Puberty, Central

INSL3 as a Biomarker of Pubertal Activation: Role in Evaluating Precocious and Delayed Puberty NCT07859787n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty NCT07710430Phase 41 site📍 Seoul LG Chem · Tests: Leuprorelin Basal LH Threshold for the Diagnosis of Central Precocious Puberty NCT07864116n/a1 site📍 Strasbourg University Hospital, Strasbourg, France IDMet (RaDiCo Cohort) (RaDiCo-IDMet) NCT05945576n/a20 sites📍 Angers📍 Besançon📍 Clermont-Ferrand Institut National de la Santé Et de la Recherche Médicale, … Idiopathic Central Precocious Puberty and Associated Neurodevelopmental Syndromes and Pathologies: Evaluation of Frequency and Comparison of Diagnostic and Developmental Characteristics NCT06720844n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy